Altimmune, Inc. (ALT)
3.49
-0.02
(-0.57%)
USD |
NASDAQ |
Apr 17, 16:00
3.47
-0.02
(-0.57%)
After-Hours: 06:55
Altimmune SG&A Expense (Quarterly) : 10.51M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.132B |
| Amgen, Inc. | 1.952B |
| Madrigal Pharmaceuticals, Inc. | 239.98M |
| CorMedix, Inc. | 39.58M |
| Viking Therapeutics, Inc. | 11.28M |